Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts

Journal of Investigative Dermatology

Volumn 107, Issue 4, 1996, Pages 615-621

  Konstantinova, Natalia V ^b   Duong, Duyen Mai T ^b   Remenyik, Eva ^b   Hazarika, Parul ^b   Chuang, Alice ^a   Duvic, Madeleine ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Chemokines; Dermal epidermal interactions; Epidermal differentiation; Psoriasis; Wound healing

Indexed keywords

INTERLEUKIN 8; MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS; WOUND HEALING;

EID: 0029838729     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12584215     Document Type: Article

References (48)

1. Appling WD, O'Brien W, Johnson D, Duvic M: Synergistic enhancement of type I and III collagen production in cultured fibroblasts by transforming growth factor B (TGF-B) and ascorbate. FEBS Lett 250:541-544, 1989
2. Asselineau D, Bernard BA, Bailly C, Darmon M, Prunieras M: Human epidermis reconstituted by culture: is it normal? J Invest Dermatol 86:181-186, 1986
3. Asselineau D, Prunieras M: Reconstruction of 'simplified' skin: control of fabrication. Br J Dermatol 111:219-222, 1984
4. Baadsgaard O, Tong P, Elder JT, Hansen ER, Ho V, Hammerberg C, Lange-Vejlsgaard G, Fox DA, Fisher G, Chan LS, Voorhees JJ, Cooper KD: UM4D4+ (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic skin lesions. J Invest Dermatol 95:275-282, 1990
5. Baker BS, Fry L: The immunology of psoriasis. Br J Dermatol 126:1-9, 1992
6. Bell E, Ivarsson X, Merrill CH: Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 76:1274-1278, 1979
7. Blanton RA, Kupper TS, McDougall JK, Dower S: Regulation of interleukin 1 and its receptor in human keratinocytes. Proc Natl Acad Sci USA 86:1273-1277, 1989
8. Breathnach SM: The skin immune system and psoriasis. Clin Exp Immunol 91:343-345, 1993
9. Chang JCC, Smith LR, Froning KJ, Schwabe BJ, Luxer JA, Caralli LL, Kurland HH, Karasek MA, Wilkinson DI, Carlo DJ: CD8+ T cells in psoriatic lesions preferentially use T-cell receptor Vb3 and/or Vb13.1 genes. Proc Natl Acad Sci USA 91:9282-9286, 1994
10. Duvic M, Chema D, Annarella M, Cho M, Esgleyes-Ribot T, Remenyik E, Ulmer R, Rapini R, Sachs PG, Clayman GL, Davies PJA, Thacher S: Keratinocyte transglutaminase expression varies in squamous cell carcinomas. J Invest Dermatol 102:462-469, 1994
11. Eedy DJ, Burrows D, Bridges JM, Jones FG: Clearance of severe psoriasis after allogenic bone marrow transplantation Br Med J 300:908, 1990
12. Elder JT, Hammerberg C, Cooper KD, Kojima T, Nair RP, Ellis CN, Voorhees JJ: Cyclosporin A rapidly inhibits epidermal cytokine expression in psoriasis lesions, but not in cytokine stimulated keratinocytes. J Invest Dermatol 101:761-766, 1993
13. Esgleyes-Ribot T, Chandraratna RA, Lew-Kaya DA, Sefton J, Duvic M: Response of psoriasis to a new topical retinoid, AGN 190168. J Am Acad Dermatol 30:581-590, 1994
14. Gillitzer R, Berger R, Mielke V, Muller C, Wolff K, Stingl G: Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol 97:73-79, 1991
15. Hammerberg C, Arend WP, Fisher GJ, Chan LS, Berger AE, Haskill JS, Voorhees JJ, Cooper KD: Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J Clin Invest 90:571-583, 1992
16. Haskill S, Peace A, Morris J, Sporn SA, Anisowicz A, Lee SW, Smith T, Martin G, Ralph P, Sager R: Identification of three related human GRO genes encoding cytokine functions. Proc Natl Acad Sci USA 87:7732-7736, 1990
17. Henseler T, Christophers E: Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13:450-456, 1985
18. Holmes WE, Lee J, Kuang W-J, Rice GC, Wood WI: Structure and functional expression of the human interleukin 8 receptor. Science 253:1278-1280, 1991
19. Kemeny L, Kenderessy AS, Ocsovszky I, Michel G, Ruzicka T, Dobozy A: Interleukin-8 induces the HLA-DR expression on cultured human keratinocytes via specific receptors. Int Arch Allergy Immunol 106:351-356, 1995
20. Kojima T, Cromie MA, Fisher GJ, Voorhees JJ, Elder JT: GRO-A mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes. J Invest Dermatol 101:767-772, 1993
21. Konohana A, Konohana I, Schroeder WT, O'Brien WR, Amagai M, Greer J, Shizimi N, Gammon WR, Siciliano M, Duvic M: Placental glutathione-S-transferase-pi mRNA is abundantly expressed in human skin. J Invest Dermatol 95:119-126, 1990
22. Krueger G, Chambers D, Shelby J: Involved and uninvolved skin from psoriatic patients: are they equally diseased? J Clin Invest 68:1548-1557, 1981
23. Krueger GG, Duvic M: Epidemiology of psoriasis: clinical issues. J Invest Dermatol 102:14S-18S, 1994
24. Krueger JG, Krane JF, Carter M, Gottlieb AB: Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 94:135S-140S, 1990
25. Larsen CG, Anderion AO, Appella E, Oppenheim JJ, Matsushima K: The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243:1464-1466, 1989
26. MacLaughlin J, Gange W, Taylor D, Smith E, Holick M: Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferative-inhibition activity of 1,25-dihydroxyvitamen D3. Proc Natl Acad Sci USA 82:5409-5412, 1985
27. Mahoney SE, Duvic M, Nickoloff BJ, Minshall M, Smith LC, Griffiths CEM, Paddock SW, Lewis DE: Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma lesions. J Clin Invest 88:174-185, 1991
28. Mansbridge JN, Knapp AM: Changes in keratinocyte maturation during wound healing. J Invest Dermatol 89:253-263, 1987
29. Matsushima K, Oppenheim JJ: Interleukin H and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1:2-13, 1989
30. McFadden J: Immunology of psoriasis: a review of Valdimarsson's hypothesis. Dermatol Today Tomorrow 18:31-33, 1990
31. Michel G, Kemeny L, Peter RU, Beetz A, Ried C, Arenberger P, Ruzicka T: Interleukin-8 receptor-mediated chemotaxis of normal human epidermal cells. FEBS Lett 305:241-243, 1992
32. Murphy PM, Tiffany HL: Cloning of complementary DNA encoding a functional interleukin-8 receptor. Science 253:1280-1283, 1991
33. Nair RP, Guo SW, Jenisch S, Henseler T, Lange EM, Terhune M, Westphal E, Christophers E, Voorhees JJ, Elder JT: Scanning chromosome 17 for psoriasis susceptibility: lack of evidence for a distal 17q locus. Hum Hered 45:219-230, 1995
34. Nickoloff BJ: The cytokine network in psoriasis (Editorial). Arch Dermatol 127:871-874, 1991
35. Nickoloff BJ, Karabin GD, Barker JNWN, Griffiths CEM, Sarma V, Mitra RS, Elder JT, Kunkel SL, Dixit VM: Cellular localization of IL-8 and its indurer, tumor necrosis factor alpha in psoriasis. Am J Pathol 138:129-140, 1990
36. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene "intercrine" family Annu Rev Immunol 9:617-648, 1991
37. Parenteau NL, Nolte CM, Bilbo P, Rosenberg M, Wilkins LM, Johnson EW, Watson S, Mason VS, Bell E: Epidermis generated in vitro: practical considerations and applications. J Cell Biochem 45:245-251, 1991
38. Saiag P, Coulomb B, Lebreton C, Bell E, Dubertret L: Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science 230:669-672, 1985
39. Schroder J-M, Enno C: Identification of C5a des arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 87:53-58, 1986
40. Sherman L, Ghiselli R, Kupper TS: Expression of interleukin 1 receptors in human epidermis: increased expression in psoriatic epidermis. J Invest Dermatol 94:578, 1990
41. Smola H, Thiekotter G, Fusenig NE: Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. Cell Biol 122:417-429, 1993
42. Sticherling M, Bornscheuer E, Schroder J-M, Chistophers E: Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin. J Invest Dermatol 96:26-30, 1991
43. Stoler A, Kopan R, Duvic M, Fuchs E: The use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. J Cell Biol 107:427-446, 1988
44. Theeuwes M, Leder RO: Hereditary insights in psoriasis. Eur J Dermatol 3:335-341, 1993
45. Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina MA, Young M, Lory D, Morris L, Wuepper KD, Stastny P, Menter A: Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264:1141-1145, 1994
46. Tuschil A, Lam C, Halsberger A, Lindley I: Interleukin-8 stimulates calcium transients and promotes epidermal cell proliferation. J Invest Dermatol 99:294-298, 1992
47. Waelti ER, Inaebnit SP, Rast HP, Hunziker T, Limat A, Braathen LR, Wiesmann U: Co-culture of human keratinocytes on post-mitotic human dermal fibroblast feeder cells: production of large amounts of interleukin 6. J Invest Dermatol 98:805-808, 1992
48. Wilson JL, Dollard SC, Chow LT, Broker TR: Epithelial-specific gene expression during differentiation of stratified primary human keratinocyte cultures. Cell Growth Differ 3:471-483, 1992